Additional considerations beyond efficacy for lithium in pediatric bipolar disorder

Bipolar Disord. 2019 Sep;21(6):558-559. doi: 10.1111/bdi.12810. Epub 2019 Jul 15.

Authors

Amanda Y Sun¹, Robert L Findling¹, Ekaterina Stepanova²

Affiliations

¹ Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Johns Hopkins University School of Medicine, Children's Mental Health Center, Baltimore, MD, USA.

PMID: 31264283
DOI: 10.1111/bdi.12810

No abstract available

Publication types

Letter
Comment

MeSH terms

Advisory Committees
Antimanic Agents
Bipolar Disorder*
Child
Humans
Lithium
Lithium Compounds

Substances

Antimanic Agents
Lithium Compounds
Lithium